Impact of COVID-19 pandemic on melanoma presentation by facility type and region in the United States.

Kim, Daniel Y; Behbahani, Sara; Hartman, Rebecca I

Kim, Daniel Y; Behbahani, Sara; Hartman, Rebecca I.

Kim DY; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
Behbahani S; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
Hartman RI; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Dermatology Section, VA Integrated Service Network 1 (VISN-1), Jamaica Plain, Massachusetts. Electronic address: rhartman@bwh.harvard.edu.

J Am Acad Dermatol ; 89(1): 175-178, 2023 Jul.

Article in English | MEDLINE | ID: covidwho-2266391

Subject(s)

COVID-19; Melanoma; Skin Neoplasms; Humans; United States/epidemiology; Pandemics; Melanoma/diagnosis; Melanoma/epidemiology; Melanoma/surgery; Skin Neoplasms/diagnosis; Skin Neoplasms/epidemiology; Skin Neoplasms/surgery; Sentinel Lymph Node Biopsy; Prognosis; Retrospective Studies

Keywords

Breslow thickness; COVID-19; Midwest; Northeast; SARS-CoV-2; South; West; academic; community; disparities; melanoma; mitotic rate; nodular; pandemic; presentation; region; sentinel lymph node; stage; ulceration

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Skin Neoplasms / COVID-19 / Melanoma Type of study: Experimental Studies Limits: Humans Country/Region as subject: North America Language: English Journal: J Am Acad Dermatol Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google